Exact Mass: 456.1856
Exact Mass Matches: 456.1856
Found 245 metabolites which its exact mass value is equals to given mass value 456.1856
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Delavirdine
Delavirdine is only found in individuals that have used or taken this drug. It is a potent, non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1. [PubChem]Delavirdine binds directly to viral reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by disrupting the enzymes catalytic site. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AG - Non-nucleoside reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent
Atrovirinone
Atrovirinone is found in fruits. Atrovirinone is a constituent of the roots of Garcinia atroviridis (gelugor) Constituent of the roots of Garcinia atroviridis (gelugor). Atrovirinone is found in fruits.
3-Hydroxymethyl-picumast
3-Isopropyl-5-(4-(((6-(4-(methylsulfonyl)phenyl)pyridin-3-yl)oxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole
Lactupicrin methyl ester
Lactupicrin methyl ester is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Lactupicrin methyl ester can be found in chicory, which makes lactupicrin methyl ester a potential biomarker for the consumption of this food product.
2,6-Bis(4-hydroxybenzyl)-3,3-dihydroxy-5-methoxybibenzyl
Lobaric acid
D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates
2-[3,5-Dimethoxy-4-[(3-methyl-2-butenyl)oxy]phenyl]-5,6,7-trimethoxy-4H-1-benzopyran-4-one
(2R,3R)-3,3,4,5,7-tetrahydroxy-3-methoxy-6-[6-hydroxy-3,7-dimethyl-2(E),7-octadienyl]flavanone
4-[2-(3-Methoxyphenyl)ethyl]-2-[4-[2-(2,5-dihydroxyphenyl)ethyl]phenoxy]phenol
alpha-Pyranose-alpha-L-Rhamnopyranosyl-(1鈥樏傗垎3)-alpha-L-rhamnopyranosyl-(1鈥樏傗垎3)-L-rhamnose|beta-Pyranose-alpha-D-Rhamnopyranosyl-(1鈥樏傗垎3)-alpha-D-rhamnopyranosyl-(1鈥樏傗垎2)-L-rhamnose
11a-hydroxy-7,8-dimethoxy-13-methyl-1a,2,3a,4,9c,9d,11,11a-octahydro-5h,10h-9b,11b-(ethanoiminomethano)-1,3-dioxa-5a-azacyclopropa[4,5]cyclohepta[1,2,3-cd]fluoranthene-5,10-dione
Dehydroaustinol
A meroterpenoid produced by Aspergillus nidulans. It has an oxygen-bridged pentacyclic structure which incorporates three lactone functionalities and a spiro union.
3,3,4,5,8-Penta-Me ether,7-O-(3-methyl-2-butenyl)-Gossypetin
alpha-D-Rhamnopyranosyl-(1鈥樏傗垎2)-alpha-L-rhamnopyranosyl-(1鈥樏傗垎3)-L-rhamnose|alpha-L-Rhamnopyranosyl-(1鈥樏傗垎2)-alpha-L-rhamnopyranosyl-(1鈥樏傗垎3)-L-rhamnose
8-(7??-hydroxy-3??,7??-dimethyl-oct-2??-enyl)quercetin|solophenol C
2-(7??-hydroxy-3??,7??-dimethyl-oct-2??-enyl)quercetin|solophenol B
1alpha,9beta-difuranoyloxy-2-oxodihydro-beta-agarofuran
3,3-Dimethoxy-2,4-diacetoxy-5-(3-acetoxy-propyl)-stilben|trans-2,4-diacetoxy-5-(3-acetoxypropyl)-3,3-dimethoxystilbene
(1S,3aR,4S,9aR)-4-(4-acetoxy-3-methoxyphenyl)-1,7-dimethoxy-1,3,3a,4,9,9a-hexahydronaphtho<2,3-c>furan-6-yl acetate|formosanol diacetate|Methyl-alpha-conidendraldiacetat|tsugacetal diacetate
2(S)-5,6,7-trihydroxy-5-prenyl-[2,2-(3,4-dihydroxy)-dimethylpyrano]-(5,6:3,4)flavanone
alpha-Pyranose-alpha-L-Rhamnopyranosyl-(1鈥樏傗垎3)-alpha-L-rhamnopyranosyl-(1鈥樏傗垎2)-L-rhamnose
9-keto Fluprostenol
PF-3845
PF-3845 is a potent, selective, irreversible and orally active inhibitor of fatty acid amide hydrolase (FAAH), with a Ki of 0.23 μM. PF-3845 is a covalent inhibitor that carbamylates FAAH's serine nucleophile. PF-3845 can reduce pain sensation, inflammation, and anxiety/depression without substantial effects on motility or cognition[1][3].
11-keto Fluprostenol
C25H28O8_(1S,2R,3R,7R,8R,9S,13R)-8-Hydroxy-2,2,2,9,13-pentamethyl-6,16-bis(methylene)-6H-spiro[pyran-3,5-[10,14,17]trioxapentacyclo[7.6.1.1~7,12~.0~1,12~.0~2,7~]heptadecane]-6,11,15-trione
C25H28O8_12H-6,13-Epoxy-8,12a-methano-2H,7H-furo[3,4:6,7]oxireno[3,4]heptaleno[3,2-c]pyran-4,9,12(6H,8H)-trione, 6a,9a,10,12b,13,13a-hexahydro-9a-hydroxy-2,2,6,8,10,12b-hexamethyl-15-methylene
2-[3,4-dihydroxy-2,2-dimethyl-8-(3-methylbut-2-enoxy)-3,4-dihydrochromen-6-yl]-5,7-dihydroxy-2,3-dihydrochromen-4-one
7-hydroxy-2,6,9,12,17,17-hexamethyl-22-methylidene-5,16,19,21-tetraoxaheptacyclo[10.8.1.1³,⁹.0²,¹¹.0³,⁷.0¹³,¹⁸.0¹⁸,²⁰]docos-13-ene-4,8,15-trione
7-hydroxy-2,6,9,12,17,17-hexamethyl-22-methylidene-5,16,19,21-tetraoxaheptacyclo[10.8.1.1³,⁹.0²,¹¹.0³,⁷.0¹³,¹⁸.0¹⁸,²⁰]docos-13-ene-4,8,15-trione_major
2-[3,4-dihydroxy-2,2-dimethyl-8-(3-methylbut-2-enoxy)-3,4-dihydrochromen-6-yl]-5,7-dihydroxy-2,3-dihydrochromen-4-one_major
7-hydroxy-2,6,9,12,17,17-hexamethyl-22-methylidene-5,16,19,21-tetraoxaheptacyclo[10.8.1.1³,?.0²,¹¹.0³,?.0¹³,¹?.0¹?,²?]docos-13-ene-4,8,15-trione
Cys His Pro Thr
Cys His Thr Pro
Cys Pro His Thr
Cys Pro Thr His
Cys Thr His Pro
Cys Thr Pro His
Asp Glu Pro Pro
Asp Pro Glu Pro
Asp Pro Pro Glu
Glu Asp Pro Pro
Glu Pro Asp Pro
Glu Pro Pro Asp
His Cys Pro Thr
His Cys Thr Pro
His Pro Cys Thr
His Pro Thr Cys
His Thr Cys Pro
His Thr Pro Cys
Pro Cys His Thr
Pro Cys Thr His
Pro Asp Glu Pro
Pro Asp Pro Glu
Pro Glu Asp Pro
Pro Glu Pro Asp
Pro His Cys Thr
Pro His Thr Cys
Pro Pro Asp Glu
Pro Pro Glu Asp
Pro Thr Cys His
Pro Thr His Cys
Ser Ser Thr Tyr
Ser Ser Tyr Thr
Ser Thr Ser Tyr
Ser Thr Tyr Ser
Ser Tyr Ser Thr
Ser Tyr Thr Ser
Thr Cys His Pro
Thr Cys Pro His
Thr His Cys Pro
Thr His Pro Cys
Thr Pro Cys His
Thr Pro His Cys
Thr Ser Ser Tyr
Thr Ser Tyr Ser
Thr Tyr Ser Ser
Tyr Ser Ser Thr
Tyr Ser Thr Ser
Tyr Thr Ser Ser
15-keto Fluprostenol
Atrovirinone
9a-hydroxy-2,2,6,8,10,12b-hexamethyl-15-methylene-6a,7,8,9a,10,12b,13,13a-octahydro-2H,9H,12H-6,13-epoxy-8,12a-methanofuro[3,4:6,7]oxireno[2,3:3,4]heptaleno[3,2-c]pyran-4,9,12(6H)-trione
1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol,dihydrochloride
1-[3-(1,3-benzodioxol-5-yloxy)propyl]-4-phenylpiperazine
1,7-Bis(3,4,5-trimethoxyphenyl)hepta-1,6-diene-3,5-dione
3-Hydroxy-9-methoxy-6-oxo-8-pentanoyl-1-pentylbenzo[b][1,4]benzodioxepine-2-carboxylic acid
(1S,4aS,11aR,12aS)-3-carbamoyl-10-(dimethylamino)-1-(dimethylazaniumyl)-4a,7-dihydroxy-4,6-dioxo-1,4,4a,6,11,11a,12,12a-octahydrotetracene-2,5-diolate
N-[1,4-dimethyl-2,3-dioxo-7-(1-piperidinyl)-6-quinoxalinyl]-4-ethylbenzenesulfonamide
(6R,7R,8S)-4-(3-fluorobenzoyl)-8-(hydroxymethyl)-7-(4-((E)-styryl)phenyl)-1,4-diazabicyclo[4.2.0]octan-2-one
alpha-L-rhamnosyl-(1->2)-alpha-L-rhamnosyl-(1->2)-alpha-L-rhamnose
Ethyl 2-[5-benzyloxy-4-(trifluoromethyl)biphenyl-3-yl]pentanoate
alpha-D-rhamnopyranosyl-(1->2)-alpha-D-rhamnopyranosyl-(1->3)-alpha-D-rhamnopyranose
alpha-D-rhamnopyranosyl-(1->3)-alpha-D-rhamnopyranosyl-(1->2)-alpha-D-rhamnopyranose
alpha-D-abequosyl-(1->3)-alpha-D-mannosyl-(1->4)-alpha-L-rhamnose
alpha-D-rhamnopyranosyl-(1->2)-[alpha-D-rhamnopyranosyl-(1->3)]-alpha-D-rhamnopyranose
[(3aR,4S,9bR)-1-(1,3-benzodioxol-5-ylmethyl)-8-[2-(4-fluorophenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide
N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide
N-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide
N-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]oxan-2-yl]ethyl]oxane-4-carboxamide
N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide
[(3aR,4R,9bR)-1-(1,3-benzodioxol-5-ylmethyl)-8-[2-(4-fluorophenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aR,4S,9bR)-4-(hydroxymethyl)-8-[2-(4-methoxyphenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(3-fluorophenyl)methanone
1-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-(2-thiazolylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone
N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide
N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide
N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]ethyl]-4-oxanecarboxamide
[(3aS,4R,9bS)-1-(1,3-benzodioxol-5-ylmethyl)-8-[2-(4-fluorophenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aS,4S,9bS)-1-(1,3-benzodioxol-5-ylmethyl)-8-[2-(4-fluorophenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aS,4S,9bS)-4-(hydroxymethyl)-8-[2-(4-methoxyphenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(3-fluorophenyl)methanone
1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-(2-thiazolylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone
(6R,7R,8R)-4-(3-fluorobenzoyl)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-4-(3-fluorobenzoyl)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8S)-4-(3-fluorobenzoyl)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
2,6-dimethyl-3,4-dihydropyridine-3,4,5-tricarboxylic acid O4-[2-(2,3-dihydroindol-1-yl)-2-oxoethyl] ester O3,O5-diethyl ester
3,4,5-trihydroxy-6-[(E)-5-oxo-1,7-diphenylhept-1-en-3-yl]oxyoxane-2-carboxylic acid
Delavirdine
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AG - Non-nucleoside reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent
minocycline(1-)
An organic anion that is the conjugate base of minocycline, obtained by deprotonation of the two enolic hydroxy groups and protonation of the non-aromatic tertiary amino group.
13,15-dimethyl 15-hydroxy-20-methoxy-17-oxa-3,13-diazaheptacyclo[12.6.2.0¹,¹⁶.0²,⁶.0³,¹⁸.0⁶,¹⁴.0⁷,¹²]docosa-7,9,11-triene-13,15-dicarboxylate
14-hydroxy-2,6,6,13,16,19-hexamethyl-7,15,17,20-tetraoxaspiro[heptacyclo[11.8.1.0¹,¹⁸.0²,¹¹.0⁵,¹⁰.0¹¹,¹⁶.0¹⁴,¹⁸]docosane-22,2'-oxirane]-4,9-diene-8,21-dione
2,18-dimethyl 17,18-dihydroxy-4-methoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7,14-tetraene-2,18-dicarboxylate
(1'r,2's,3r,9's,12'r,13'r)-12'-hydroxy-2,2,2',6',9',13'-hexamethyl-16'-methylidene-10',14'-dioxaspiro[pyran-3,5'-tetracyclo[7.6.1.0¹,¹².0²,⁷]hexadecan]-6'-ene-6,8',11',15'-tetrone
(7r,8s,8as)-8-(acetyloxy)-7-methyl-6-oxo-3-[(1e)-prop-1-en-1-yl]-8,8a-dihydro-1h-isochromen-7-yl 2,4-dimethoxy-6-methylbenzoate
{2-[4-(acetyloxy)-3-methoxyphenyl]-5-[3-(acetyloxy)propyl]-2,3-dihydro-1-benzofuran-3-yl}methyl acetate
3-(4-amino-5-hydroxy-6-methyloxan-2-yl)-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaene-7,12-diol
(1r,2s,4s,7s,9r,10r,14r)-7-(furan-3-yl)-9-methyl-5,11,15-trioxo-6,16-dioxatetracyclo[8.7.0.0¹,¹⁴.0⁴,⁹]heptadecan-2-yl (2z)-2-methylbut-2-enoate
8-hydroxy-2,2',2',9,13-pentamethyl-6,16-dimethylidene-10,14,17-trioxaspiro[pentacyclo[7.6.1.1⁷,¹².0¹,¹².0²,⁷]heptadecane-5,3'-pyran]-6',11,15-trione
2,18-dimethyl (1s,9r,16r,17r,18r,21r)-17,18-dihydroxy-4-methoxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7,14-tetraene-2,18-dicarboxylate
(1s,3ar,4s,9ar)-4-[4-(acetyloxy)-3-methoxyphenyl]-1,7-dimethoxy-1h,3h,3ah,4h,9h,9ah-naphtho[2,3-c]furan-6-yl acetate
15,16-epoxy-1-oxo-2,13(16),14-clerodatriene-17,12:18,19-diolide; (ent-8βh,12βh)-form,2,3-dihydro,6α-angeloyloxy
{"Ingredient_id": "HBIN001568","Ingredient_name": "15,16-epoxy-1-oxo-2,13(16),14-clerodatriene-17,12:18,19-diolide; (ent-8\u03b2h,12\u03b2h)-form,2,3-dihydro,6\u03b1-angeloyloxy","Alias": "NA","Ingredient_formula": "C25H28O8","Ingredient_Smile": "NA","Ingredient_weight": "456.48","OB_score": "NA","CAS_id": "96888-53-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9307","PubChem_id": "NA","DrugBank_id": "NA"}
2',6'-bis(p-hydroxybenzyl)-3,3'-dihydroxy-5-methoxybibenzyl
{"Ingredient_id": "HBIN004864","Ingredient_name": "2',6'-bis(p-hydroxybenzyl)-3,3'-dihydroxy-5-methoxybibenzyl","Alias": "NA","Ingredient_formula": "C29H28O5","Ingredient_Smile": "COC1=CC(=CC(=C1)O)CCC2=C(C=CC(=C2CC3=CC=C(C=C3)O)O)CC4=CC=C(C=C4)O","Ingredient_weight": "456.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2456","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "67233527","DrugBank_id": "NA"}
3′, 3′-dihydroxy- 5-methoxybibenzyl
{"Ingredient_id": "HBIN007175","Ingredient_name": "3\u2032, 3\u2032-dihydroxy- 5-methoxybibenzyl","Alias": "NA","Ingredient_formula": "C29H28O5","Ingredient_Smile": "COC1=CC(=CC(=C1)O)CCC2=C(C=CC(=C2CC3=CC=C(C=C3)O)O)CC4=CC=C(C=C4)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41958","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}